BioRegenx, Inc.
BRGX
$0.01
$0.0041.11%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.86% | -13.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.86% | -13.41% | |||
| Cost of Revenue | -12.94% | -14.30% | |||
| Gross Profit | 20.96% | -13.18% | |||
| SG&A Expenses | -5.39% | -23.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.69% | -21.84% | |||
| Operating Income | 92.08% | 44.29% | |||
| Income Before Tax | 54.80% | 33.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 54.80% | 33.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.80% | 33.20% | |||
| EBIT | 92.08% | 44.29% | |||
| EBITDA | 105.58% | 61.21% | |||
| EPS Basic | 50.00% | 33.33% | |||
| Normalized Basic EPS | 0.00% | 50.00% | |||
| EPS Diluted | 50.00% | 33.33% | |||
| Normalized Diluted EPS | 0.00% | 50.00% | |||
| Average Basic Shares Outstanding | 0.17% | 0.23% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||